222 related articles for article (PubMed ID: 30909681)
1. Serum Levels of APRIL Increase in Patients with Glioma, Meningioma and Schwannoma.
Fouladseresht H; Ziaee SM; Erfani N; Doroudchi M
Asian Pac J Cancer Prev; 2019 Mar; 20(3):751-756. PubMed ID: 30909681
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum IL-17A but not IL-6 in glioma versus meningioma and schwannoma.
Doroudchi M; Pishe ZG; Malekzadeh M; Golmoghaddam H; Taghipour M; Ghaderi A
Asian Pac J Cancer Prev; 2013; 14(9):5225-30. PubMed ID: 24175805
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of VEGF, FGF and PDGF and Serum Levels of Inflammatory Cytokines in Patients with Glioma and Meningioma in Southern Iran.
Shamsdin SA; Mehrafshan A; Rakei SM; Mehrabani D
Asian Pac J Cancer Prev; 2019 Oct; 20(10):2883-2890. PubMed ID: 31653130
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of high sensitivity C-reactive protein and interleukin-6 in glioma and meningioma patients.
Bunevicius A; Radziunas A; Tamasauskas S; Tamasauskas A; Laws ER; Iervasi G; Bunevicius R; Deltuva V
J Neurooncol; 2018 Jun; 138(2):351-358. PubMed ID: 29460097
[TBL] [Abstract][Full Text] [Related]
5. Circulating Levels of Thrombospondin-1 and Thrombospondin-2 in Patients with Common Brain Tumors.
Kemerdere R; Akgun MY; Toklu S; Aydin S; Orhan B; Inal BB; Korkmaz TS; Aktas B; Kacira T; Tanriverdi T
Turk Neurosurg; 2021; 31(3):399-403. PubMed ID: 33759165
[TBL] [Abstract][Full Text] [Related]
6. Quantification of fibrin degradation products in glioma and meningioma patients.
Can O; Erdemgil Y; Yildirim ZZ; Ozduman K; Pamir MN; Sav A; Ozpinar A
Cancer Biomark; 2014; 14(4):253-8. PubMed ID: 24934368
[TBL] [Abstract][Full Text] [Related]
7. Circulating progenitor cells: a comparison of patients with glioblastoma or meningioma.
Alexiou GA; Vartholomatos G; Karamoutsios A; Batistatou A; Kyritsis AP; Voulgaris S
Acta Neurol Belg; 2013 Mar; 113(1):7-11. PubMed ID: 22688590
[TBL] [Abstract][Full Text] [Related]
8. Investigating the Levels of Soluble Extracellular Domain of HER2 Protein in the Sera of Meningioma Patients.
Abtahi S; Hakimrabet S; Malekzadeh M; Deghanian AR; Ghaderi A
Turk Neurosurg; 2019; 29(1):9-13. PubMed ID: 29384187
[TBL] [Abstract][Full Text] [Related]
9. Elevation of serum ceruloplasmin levels in brain tumours.
Manjula S; Aroor AR; Raja A; Rao SN; Rao A
Acta Neurol Scand; 1992 Aug; 86(2):156-8. PubMed ID: 1414225
[TBL] [Abstract][Full Text] [Related]
10. Expressions of Endocan in Patients with Meningiomas and Gliomas.
Atukeren P; Kunbaz A; Turk O; Kemerdere R; Ulu MO; Turkmen Inanir N; Tanriverdi T
Dis Markers; 2016; 2016():7157039. PubMed ID: 27528791
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
[TBL] [Abstract][Full Text] [Related]
12. Dynamic susceptibility contrast and dynamic contrast-enhanced MRI characteristics to distinguish microcystic meningiomas from traditional Grade I meningiomas and high-grade gliomas.
Hussain NS; Moisi MD; Keogh B; McCullough BJ; Rostad S; Newell D; Gwinn R; Foltz G; Mayberg M; Aguedan B; Good V; Fouke SJ
J Neurosurg; 2017 Apr; 126(4):1220-1226. PubMed ID: 27285539
[TBL] [Abstract][Full Text] [Related]
13. Nrf2 Expressions Correlate with WHO Grades in Gliomas and Meningiomas.
Tsai WC; Hueng DY; Lin CR; Yang TC; Gao HW
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187376
[TBL] [Abstract][Full Text] [Related]
14. Haemostatic abnormalities in brain tumours.
Singh VP; Jain D; Mohan R; Bhatia R; Bhargava M
Acta Neurochir (Wien); 1990; 102(3-4):103-7. PubMed ID: 2336975
[TBL] [Abstract][Full Text] [Related]
15. Serum cholesterol and primary brain tumours: a case-control study.
Abramson ZH; Kark JD
Br J Cancer; 1985 Jul; 52(1):93-8. PubMed ID: 4015954
[TBL] [Abstract][Full Text] [Related]
16. Serum TIMP1 and TIMP2 concentration in patients with different grades of meningioma.
Mashayekhi F; Saberi A; Mashayekhi S
Clin Neurol Neurosurg; 2018 Jul; 170():84-87. PubMed ID: 29753168
[TBL] [Abstract][Full Text] [Related]
17. Similar immunity profiles in patients with meningioma and glioma tumors despite differences in the apoptosis and necrosis of circulating lymphocyte and monocyte populations.
Kataki A; Skandami V; Memos N; Nikolopoulou M; Oikonomou V; Androulis A; Konstadoulakis MM; Zografos CG
J Neurosurg Sci; 2014 Mar; 58(1):9-15. PubMed ID: 24614787
[TBL] [Abstract][Full Text] [Related]
18. Assessment of tumor blood flow and its correlation with histopathologic features in skull base meningiomas and schwannomas by using pseudo-continuous arterial spin labeling images.
Yamamoto T; Takeuchi H; Kinoshita K; Kosaka N; Kimura H
Eur J Radiol; 2014 May; 83(5):817-23. PubMed ID: 24581592
[TBL] [Abstract][Full Text] [Related]
19. [Measurement of blood polyamines in patients with brain tumor--special reference to relationship between the blood levels of spermidine and spermine, and histological malignancy in patients with glioma (author's transl)].
Terabayashi T
No To Shinkei; 1977 Nov; 29(11):1215-20. PubMed ID: 337979
[No Abstract] [Full Text] [Related]
20. Perfusion imaging of brain tumors using arterial spin-labeling: correlation with histopathologic vascular density.
Noguchi T; Yoshiura T; Hiwatashi A; Togao O; Yamashita K; Nagao E; Shono T; Mizoguchi M; Nagata S; Sasaki T; Suzuki SO; Iwaki T; Kobayashi K; Mihara F; Honda H
AJNR Am J Neuroradiol; 2008 Apr; 29(4):688-93. PubMed ID: 18184842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
